BSP Medical

Company Overview

Snapshot

Founded in April 2018 by Amir Beker, BSP Medical operates with 1–10 employees. The company has secured seed funding across one round, focusing on developing noninvasive solutions for cardiac disease diagnosis.

Business overview

BSP Medical is a biomedical technology company specializing in noninvasive solutions for diagnosing cardiac diseases. The company develops a range of electrocardiogram (ECG) products based on its proprietary HyperQ technology, offering complete systems for routine clinical use, research-oriented systems, and OEM products. Its HyperQ Analyzer Stress software module analyzes stress-test ECGs by detecting changes in the high-frequency component of the QRS segment, while HyperQ Analyzer Rest facilitates early detection of acute coronary artery disease on resting ECG systems. BSP Medical serves the healthcare industry, particularly clinics, hospitals, and healthcare providers, operating within the Digital Health and Medical Technologies sectors.

Company Intelligence Q&A

What is BSP Medical's core technology?

BSP Medical's core technology is HyperQ, which forms the basis for its electrocardiogram (ECG) products designed for noninvasive diagnosis of cardiac diseases.

When was BSP Medical founded?

BSP Medical was founded in April 2018.

Who is the founder of BSP Medical?

Amir Beker is the founder and CEO of BSP Medical.

What specific products does BSP Medical offer?

BSP Medical offers products such as HyperQ Analyzer Stress, a software module for analyzing stress-test ECGs, and HyperQ Analyzer Rest, a software module for early detection of acute coronary artery disease on resting ECG systems.

What markets does BSP Medical target?

BSP Medical targets the global, Israeli, and Chinese markets, serving healthcare providers, hospitals, and clinics with its cardiac diagnostic solutions.